Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.14 - $0.23 $21 - $35
-156 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$0.22 - $0.47 $8,270 - $17,667
-37,591 Reduced 99.59%
156 $0
Q2 2021

Aug 12, 2021

BUY
$0.97 - $1.32 $4,717 - $6,419
4,863 Added 14.79%
37,747 $43,000
Q1 2021

Apr 26, 2021

BUY
$1.24 - $3.3 $19,983 - $53,182
16,116 Added 96.11%
32,884 $41,000
Q4 2020

Feb 02, 2021

BUY
$1.61 - $2.23 $26,996 - $37,392
16,768 New
16,768 $32,000

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $362M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.